AstraZeneca opens research center as UK builds science hub

- Advertisement -


Prince Charles is praising Cambridge as a center of scientific collaboration as pharmaceutical company AstraZeneca opened a £1 billion ($1.34 billion) research facility there on Tuesday.

- Advertisement -

- Advertisement -

LONDON – Prince Charles on Tuesday praised Cambridge as a center of scientific collaboration as pharmaceutical company AstraZeneca opened a £1 billion ($1.34 billion) research center to help develop one of the first COVID-19 vaccines. was expected to do.

The University of Cambridge will house more than 2,200 research scientists on its 19,000-square-metre (over 200,000 sq ft) campus. It joins a group of businesses seeking to make Cambridge a center for life science research, as California’s Silicon Valley is for the technology industry.

- Advertisement -

“Having studied at Cambridge … more than 50 years ago, one thing I’ve always loved about this city is how it attracts union of minds, unique cross-disciplinary interactions Promotes and nurtures collaboration and ingenuity,’ Charles said at the official opening.

The Cambridge Life Sciences Cluster comprises 631 companies that employ approximately 21,000 people and generate annual revenue of £7 billion, according to Cambridge Ahead, which drives business development in the city.

AstraZeneca worked with the University of Oxford to develop one of the first COVID-19 vaccines approved by regulators in the UK, EU and other countries. The vaccine is widely used in dozens of developing countries because AstraZeneca promises to keep costs down by selling it to low- and middle-income countries on a non-profit basis.

AstraZeneca also plans to ask the US Food and Drug Administration to approve the vaccine.

,

Follow all stories on the pandemic at .

,

- Advertisement -

Stay on top - Get the daily news in your inbox

DMCA / Correction Notice

Recent Articles

Related Stories

Stay on top - Get the daily news in your inbox